Protective neutralizing epitopes in SARS‐CoV‐2

The COVID‐19 pandemic has caused an unprecedented health crisis and economic burden worldwide. Its etiological agent SARS‐CoV‐2, a new virus in the coronavirus family, has infected hundreds of millions of people worldwide. SARS‐CoV‐2 has evolved over the past 2 years to increase its transmissibility...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Immunological reviews Jg. 310; H. 1; S. 76 - 92
Hauptverfasser:	Liu, Hejun, Wilson, Ian A.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England Wiley Subscription Services, Inc 01.09.2022 John Wiley and Sons Inc
Schlagworte:	Antibodies antibody coronavirus Coronaviruses COVID-19 epitope Epitopes Immune response Immune system Infections Invited Review Neutralizing Pandemics SARS‐CoV‐2 SARS‐CoV‐2 Vaccines Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 vaccine variants Viral diseases Viral infections Viruses coronavirus SARS-CoV-2 vaccine antibody variants epitope
ISSN:	0105-2896, 1600-065X, 1600-065X
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!